Autophagic flux is increased in peripheral blood mononuclear cells in atherosclerotic vascular disease and associates inversely with adverse cardiovascular events
Authors:
- Bronwyn BeeldersBBBronwyn Beelders
- Leanne K. HeinLHLeanne K. Hein
- Naomi WattchowNWNaomi Wattchow
- Mau T. NguyenMNMau T. Nguyen
- Shabnam TorabiardakaniSTShabnam Torabiardakani
- Thalia SalagarasTSThalia Salagaras
- Sanuri LiyanageSLSanuri Liyanage
- Christina A. BursillCBChristina A. Bursill
- Robert FitridgeRFRobert Fitridge
- Neil McMillanNMNeil McMillan
- Christopher L. DelaneyCDChristopher L. Delaney
- Timothy J. SargeantTSTimothy J. Sargeant
Preprint
Abstract
Background: Autophagy is a homeostatic pathway supporting stress adaptation and is dysregulated in atherosclerosis. Its potential as a biomarker or therapeutic target in atherosclerotic vascular disease (ASVD) remains incompletely defined. We measured autophagic flux in peripheral blood mononuclear cells (PBMCs) from patients with peripheral arterial disease (PAD) or carotid stenosis (CS), compared with healthy controls, and explored clinical outcome associations. Methods: Ninety-four patients with PAD or CS and 19 healthy controls were studied. Autophagic flux was quantified from fresh blood using a validated ex vivo chloroquine-inhibition ELISA measuring LC3B-II accumulation. Major adverse cardiovascular events (MACE) and major adverse limb events (MALE) were ascertained over a median follow-up of 828 days. Results: The ASVD cohort comprised claudication (n = 16), chronic limb-threatening ischemia (CLTI; n = 49), and CS (n = 29). Autophagic flux was higher in ASVD than controls (mean 281.4 vs. 182.3 ng LC3B-II/mg protein/h; p < 0.0001) and remained independently associated after multivariable adjustment. Within CLTI, concurrent infection was associated with lower flux (p = 0.001), approaching control levels (p = 0.327). In CLTI, higher flux quartiles were associated with lower MACE risk, most strongly for quartile 3 (hazard ratio 0.07 vs. quartile 1, 95% CI 0.01–0.50; p = 0.009). Conclusion: Autophagic flux is elevated in PBMCs from ASVD patients, independent of age and sex. Attenuated flux in CLTI with concurrent infection may indicate autophagic exhaustion in advanced disease. The association between higher flux and lower MACE in CLTI suggests prognostic utility, warranting evaluation in larger prospective studies.Keywords
This publication has 43 references indexed in Scilit:
- ATG9A-mediated autophagy prevents inflammatory skin disease by limiting TNFR1-driven STING activation and ZBP1-dependent cell deathImmunity, 2025
- Basal autophagic flux measured in blood correlates positively with age in adults at increased risk of type 2 diabetesGeroScience, 2023
- The role of redox-mediated lysosomal dysfunction and therapeutic strategiesBiomedicine & Pharmacotherapy, 2023
- The mTOR–lysosome axis at the centre of ageingFEBS Open Bio, 2021
- Autophagy protects peripheral blood mononuclear cells against inflammation, oxidative and nitrosative stress in diabetic dyslipidemiaFree Radical Biology and Medicine, 2019
- Defective autophagy in vascular smooth muscle cells enhances atherosclerotic plaque instabilityBiochemical and Biophysical Research Communications, 2018
- Autophagy Links Inflammasomes to Atherosclerotic ProgressionCell Metabolism, 2012
- Macrophage Autophagy Plays a Protective Role in Advanced AtherosclerosisCell Metabolism, 2012
- Autophagy and AgingCell, 2011
- Inflammatory Profiling of Peripheral Arterial DiseaseAnnals of Vascular Surgery, 2009